| 摘要 |
The invention is concerned with compounds of general formula (I), wherein R<1> and R<2> each individually signify lower-alkyl or amino, A signifies A<1>, A<2>, A<3>, A<4>, A<5>, A<6> or A<7>; B signifies hydrogen in A<4>, A<5> and A<6>; (i) in A<1>-A<6>; lower-alkoxy in A<4>-A<6>; and lower alkyl, styryl, phenylethynyl or benzoyloxy-lower-alkyl in A<1> and A<2>; n signifies 0-2; m, p signify 0, 1 and R<3>, R<4>, R<5> and R<6> each independently signify hydrogen, halogen, lower-alkyl, trifluoromethyl, lower-alkoxy or nitro, and pharmaceutically acceptable acid addition salts thereof. These compounds can be used in the control or prevention of illnesses which are caused by disorders of the dopamine system. Psychotic illnesses such as e.g. schizophrenia belong to these.
|
